DOA Rapid Screen Test – iCARE Drug of Abuse Diagnostic Kits
With a remarkable degree of precision and tolerance, the iCARE DOA Rapid Screen tests or drug screening tests tests use a unique humanised monoclonal to specifically define individual DOA (Drugs of Abuse) and related equivalents in specimens. As manufacturers of DOA Rapid tests, which depend on the drug-competitive inhibitory activity confirmatory testing, enable for speedy diagnoses that are lateral flow, measurable, and straightforward and uncomplicated to examine. As wholesale suppliers, we supply a variety of Rapid Test Kits that deliver precise findings right away.
The slashed off accumulation for particular drug of abuse (DOA) and its intermediates has also been formed for almost all of our DOA diagnostic test equipment at the exposure requirements established by NIDA (the National Institute on Drug Abuse of the United States) for the presumptive identification of associated illicit substances in urine samples collected.
Jal Innovation (Singapore) Pte Ltd as exporters, we provide a variety of diagnostic items in bulk supply that are utilised in pathology labs, hospitals, residences, and other facilities for various tests, researching, and development objectives.
The urine diagnostic tests for DOA are extremely specific in nature;
- The outcomes of iCARE DOA testing may be viewed immediately without the use of additional apparatus.
- These DOA Rapid tests do not necessitate the use of any additional reagents.
- iCARE DOA diagnostic kits are employed to check urine samples for the existence of associated drugs of abuse and their intermediates.
- Strips, cassettes, and multi-drug panels are provided in iCARE DOA testing equipment.
- Two, four, five, six, and ten multi-drug test boards are offered (variations are up to the client).
Amphetamine, Barbiturates, Benzodiazepines, Cocaine, Ecstasy, Ketamine, Marijuana, Methadone, Methamphetamine, Morphine,Opiate, Methamphetamine
